PCR fluorescence

PCR manawa maoli Multiplex | ʻenehana piʻo hoʻoheheʻe | Pololei | ʻŌnaehana UNG | Reagent wai a me ka lyophilized

PCR fluorescence

  • Ua hui pū ʻia nā pathogens hanu

    Ua hui pū ʻia nā pathogens hanu

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka maʻi influenza A, ka maʻi influenza B, ka maʻi respiratory syncytial, adenovirus, human rhinovirus a me ka mycoplasma pneumoniae nucleic acids i loko o nā swab nasopharyngeal kanaka a me nā laʻana swab oropharyngeal. Hiki ke hoʻohana ʻia nā hopena hoʻāʻo no ke kōkua ʻana i ka ʻike ʻana i nā maʻi pathogen hanu, a hāʻawi i ke kumu diagnostic molecular kōkua no ka ʻike ʻana a me ka mālama ʻana i nā maʻi pathogen hanu.

  • 14 ʻAno o ka maʻi ʻaʻai Genitourinary Tract Pathogen

    14 ʻAno o ka maʻi ʻaʻai Genitourinary Tract Pathogen

    Ua manaʻo ʻia kēia pahu hana no ka ʻike ʻana i ka Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma hominis (Mh), Herpes simplex virus type 1 (HSV1), Ureaplasma urealyticum (UU), Herpes simplex virus type 2 (HSV2), Ureaplasma parvum (UP), Mycoplasma genitalium (Mg), Candida albicans (CA), Gardnerella vaginalis (GV), Trichomonal vaginitis (TV), Group B streptococci (GBS), Haemophilus ducreyi (HD), a me Treponema pallidum (TP) i loko o ka mimi, ka swab urethral kāne, ka swab cervical wahine, a me nā laʻana swab vaginal wahine, a hāʻawi i ke kōkua i ka ʻike a me ka mālama ʻana i nā maʻi me nā maʻi genitourinary tract.

  • SARS-CoV-2/maʻi palū A/maʻi palū B

    SARS-CoV-2/maʻi palū A/maʻi palū B

    He kūpono kēia pahu no ka ʻike ʻana i ka SARS-CoV-2, ka maʻi influenza A a me ka maʻi influenza B nucleic acid o nā laʻana swab nasopharyngeal a me nā laʻana swab oropharyngeal o ka poʻe i manaʻo ʻia he maʻi SARS-CoV-2, influenza A a me ka maʻi influenza B. Hiki ke hoʻohana ʻia i nā hihia pneumonia i manaʻo ʻia a me nā hihia cluster i manaʻo ʻia a no ka ʻike ʻana a me ka ʻike ʻana i ka SARS-CoV-2, influenza A a me ka maʻi influenza B nucleic acid i nā laʻana swab nasopharyngeal a me nā laʻana swab oropharyngeal o ka maʻi Coronavirus hou i nā kūlana ʻē aʻe.

  • ʻO Klebsiella Pneumoniae, Acinetobacter Baumannii a me Pseudomonas Aeruginosa a me nā Genes Resistance Drug (KPC, NDM, OXA48 a me IMP) Multiplex

    ʻO Klebsiella Pneumoniae, Acinetobacter Baumannii a me Pseudomonas Aeruginosa a me nā Genes Resistance Drug (KPC, NDM, OXA48 a me IMP) Multiplex

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka Klebsiella pneumoniae (KPN), Acinetobacter baumannii (Aba), Pseudomonas aeruginosa (PA) a me ʻehā mau genes kūʻē carbapenem (e komo pū ana me KPC, NDM, OXA48 a me IMP) i loko o nā laʻana sputum kanaka, e hāʻawi i ke kumu o ke alakaʻi ʻana i ka hōʻailona lapaʻau, ka mālama ʻana a me ka lāʻau lapaʻau no nā poʻe maʻi me ka maʻi bacteria i manaʻo ʻia.

  • ʻO ka Mycoplasma Pneumoniae (MP)

    ʻO ka Mycoplasma Pneumoniae (MP)

    Hoʻohana ʻia kēia huahana no ka ʻike qualitative in vitro o ka Mycoplasma pneumoniae (MP) nucleic acid i loko o ka sputum kanaka a me nā laʻana swab oropharyngeal.

  • ʻO Staphylococcus Aureus a me Methicillin-Resistant Staphylococcus Aureus Nucleic Acid Detection Kit

    ʻO Staphylococcus Aureus a me Methicillin-Resistant Staphylococcus Aureus Nucleic Acid Detection Kit

    Kōmike Huahana

    HWTS-OT062WA, HWTS-OT062WB, HWTS-OT062WC, HWTS-OT062WD, HWTS-OT062WE

    ʻAe ʻia ka huahana

    CE, AMMPS

  • ʻO ke gene A/B toxin Clostridium difficile(C.diff)

    ʻO ke gene A/B toxin Clostridium difficile(C.diff)

    Ua manaʻo ʻia kēia pahu hana no ka ʻike qualitative in vitro o ka gene clostridium difficile toxin A a me ka gene toxin B i loko o nā hāpana ʻōpala mai nā poʻe maʻi me ka maʻi clostridium difficile i manaʻo ʻia.

  • ʻO ke Gene Kū'ē Carbapenem (KPC/NDM/OXA 48/OXA 23/VIM/IMP)

    ʻO ke Gene Kū'ē Carbapenem (KPC/NDM/OXA 48/OXA 23/VIM/IMP)

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i nā genes kūʻē carbapenem i loko o nā laʻana sputum kanaka, nā laʻana swab rectal a i ʻole nā ​​kolone maʻemaʻe, me KPC (Klebsiella pneumonia carbapenemase), NDM (New Delhi metallo-β-lactamase 1), OXA48 (oxacillinase 48), OXA23 (oxacillinase 23), VIM (Verona Imipenemase), a me IMP (Imipenemase).

  • ʻO ka maʻi Influenza A Universal/H1/H3

    ʻO ka maʻi Influenza A Universal/H1/H3

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka maʻi influenza A universal type, H1 type a me H3 type nucleic acid i nā laʻana swab nasopharyngeal kanaka.

  • Ka maʻi Ebola o Zaire

    Ka maʻi Ebola o Zaire

    He kūpono kēia pahu hana no ka ʻike qualitative o ka Zaire Ebola virus nucleic acid i loko o nā laʻana serum a plasma paha o nā maʻi i manaʻo ʻia he maʻi Zaire Ebola (ZEBOV).

  • ʻO Adenovirus Universal

    ʻO Adenovirus Universal

    Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o ka adenovirus nucleic acid i loko o ka nasopharyngeal swab a me ka ʻāʻī swab laʻana.

  • 4 ʻAno o nā maʻi hanu

    4 ʻAno o nā maʻi hanu

    Hoʻohana ʻia kēia kime no ka ʻike ʻana i ka qualitative o2019-nCoV, ka maʻi influenza A, ka maʻi influenza B a me ka maʻi respiratory syncytial nucleic acidsi loko o ke kanakaonā hāpana swab ropharyngeal.